1. Gowda H, Norton R, White A, Kandasamy Y. Late-onset neonatal sepsis-A 10-year review from North Queensland, Australia. Pediatr Infect Dis J 2017;36(9):883-8.
2. Ouchenir L, Renaud C, Khan S, Bitnun A, Boisvert AA, McDonald J, et al. The epidemiology, management, and outcomes of bacterial meningitis in infants. Pediatrics 2017;140(1):e20170476.
3. Mohsen L, Ramy N, Saied D, Akmal D, Salama N, Abdel Haleim MM, et al. Emerging antimicrobial resistance in early and late-onset neonatal sepsis. Antimicrob Resist Infect Control 2017;6:63.
4. Tsai MH, Chu SM, Hsu JF, Lien R, Huang HR, Chiang MC, et al. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics 2014;133(2):e322-9.
5. Folgori L, Tersigni C, Hsia Y, Kortsalioudaki C, Heath P, Sharland M, et al. The relationship between Gram-negative colonization and bloodstream infections in neonates: a systemic review and meta-analysis. Clin Microbiol Infect 2018;24(3):251-7.
6. Wu IH, Tsai MH, Lai MY, Hsu LF, Chiang MC, Lien R, et al. Incidence, clinical features, and implications on outcomes of neonatal late-onset sepsis with concurrent infectious focus. BMC Infect Dis 2017;17(1):465.
7. Hsu JF, Chu SM, Huang YC, Lien R, Huang HR, Lee CW, et al. Predictors of clinical and microbiological treatment failure in neonatal bloodstream infections. Clin Microbiol Infect 2015;21(5):482.e9-17.
8. Investigators of the Delhi Neonatal Infection Society (DeNIS) collaboration. Characterization and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centers in Delhi, India: a cohort study. Lancet Glob Health 2016;4(10):e752-60.
9. Dharmapalan D, Shet A, Yewale V, Sharland M. High reported rates of antimicrobial resistance in India neonatal and pediatric bloodstream infections. J Pediatric Infect Dis Soc 2017;6(3):e62-e68.
10. Gkentzi D, Kortsalioudaki C, Cailes BC, Zaoutis T, Kopsidas J, Tsolia M, et al. Epidemiology of infections and antimicrobial use in Greek Neonatal Units. Arch Dis Child Fetal Neonatal Ed. 2019;104(3):F293-F297.
11. Lacy MK, Stryjewski ME, Wang W, Hardin TC, Nogid B, Luke DR, et al. Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. Clin Infect Dis 2015;61(Suppl 2):S87-93.
12. Fitzpatrick JM, Biswas JS, Edgeworth JD, Islam J, Jenkins N, Judge R, et al. Gram-negative bacteremia: a multi-center prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals. Clin Microbiol Infect 2016;22(3):244-51.
13. Martoletti M, Giannella M, Lewis R, Caraceni P, Tedeschi S, Paul M, et al. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. Clin Microbiol Infect 2018;24(5):546.e1-e8.
14. Wang W, Jiang T, Zhang W, Li C, Chen J, Xiang D, et al. Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection. Am J Infect Control. 2017;45(1):59-64.
15. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A et al. Antimicrobial use and the influence of inadequate empiric antimicrobial therapy on the outcomes of nosocomial bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004; 25: 735-41.
16. Tsai MH, Hsu JF, Chu SM, Lien R, Huang HR, Chiang MC, et al. Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J 2014;33(1):e7-e13.
17. Sotto A, Lefrant JY, Fabbro-Peray P et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002; 50: 569-76.
18. Valles J, Rello J, Ochagavia A et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003; 123: 1615-24.
19. Gray JE, Richardson DK, McCormick MC et al. Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics 1992; 90: 561-7.
20. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA, 2012.
21. Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
23. Kermorvant-Duchemin E, Laborie S, Rabilloud M et al. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med 2008; 9: 186 –91.
24. Harbarth S, Garbino J, Pugin J et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-35.
25. McDonald JR, Friedman ND, Stout JE et al. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 2005; 165: 308-13.
26. Le J, Nguyen T, Okamoto M et al. Impact of empiric antibiotic use on the development of infection caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit. Pediatr Infect Dis J 2008; 27: 314-8.
27. Linkin DR, Fishman NO, Patel JB et al. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004; 25: 781-3.
28. Ong DS, Jongerden IP, Buiting AG, et al. Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care unit. Crit Care Med 2011; 39: 2458-63.
29. Ye Y, Li JB, Ye DQ, Jiang ZJ. Enterobacter bacteremia: clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital. Infection 2006; 34: 252-7.
30. Fraser A, Paul M, Almanasreh N et al. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 2006; 119: 970-6.
31. Marra AR, de Almeida SM, Correa L et al. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. Am J Infect Control 2009; 37: 204-9.
32. Cook PP, Catrou PG, Christie JD et al. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 2004; 53: 853-9.
33. Maltezou HC, Tryfinopoulou K, Katerelos P et al. Consecutive Serratia marcescens multiclone outbreaks in a neonatal intensive care unit. Am J Infect Control 2012; 40: 637-42.
34. Simmonds A, Munoz J, Aguero-Rosenfeld M et al. Outbreak of Acinetobacter infection in extremely low birth weight neonates. Pediatr Infect Dis J 2009; 28: 210-4.
35. Makhoul IR, Sujov P, Smolkin T et al. Pathogen-specific early mortality in very low birth weight infants with late-onset sepsis: a national survey. Clin Infect Dis 2005; 40: 218-24.
36. Abdel-Hady H, Hawas S, EI-Daker M, EI-Kady R. Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J Perinatol 2008; 28: 685-90.